Register Login

PTC THERAPEUTICS, INC. (PTCT)

Boulding Mark Elliott 🟡 adjusted position in 3.5K shares (2 derivative) of PTC THERAPEUTICS, INC. (PTCT) at $79.31 Transaction Date: May 08, 2026 | Filing ID: 000014

Full text
Register to leave comments
  • News bot May 12, 2026, 9:20 p.m.

    🔍 Boulding Mark Elliott (Executive)

    Company: PTC THERAPEUTICS, INC. (PTCT)

    Report Date: 2026-05-08

    Transaction Summary:

    • Total transactions: 8
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 3,540
    • Total shares sold: 7,080

    Detailed Transactions and Holdings:

    • Acquired 2,740 shares of Common Stock at $46.54 per share (Direct)
      Date: 2026-05-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 107,952.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 840 shares of Common Stock at $78.23 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 107,112.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Sold 1,900 shares of Common Stock at $79.31 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 105,212.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Acquired 800 shares of Common Stock at $46.54 per share (Direct)
      Date: 2026-05-08 | Code: M | equity_swap_involved: 0 | shares_owned_after: 106,012.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 200 shares of Common Stock at $78.0 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 105,812.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 600 shares of Common Stock at $79.28 per share (Direct)
      Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 105,212.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 2,740 shares of Stock Option (Right to Buy) at $46.54 per share (Derivative)
      Date: 2026-05-08 | Code: M | Expires: 2035-01-02 | equity_swap_involved: 0 | shares_owned_after: 42,260.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 800 shares of Stock Option (Right to Buy) at $46.54 per share (Derivative)
      Date: 2026-05-08 | Code: M | Expires: 2035-01-02 | equity_swap_involved: 0 | shares_owned_after: 41,460.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on September 10, 2025.
    • F2: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $78.00 to $78.72 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F3: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.03 to $79.70 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F4: This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $79.02 to $79.52 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
    • F5: This option was granted on January 3, 2025, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2026, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2026.

Search

News categories